Cargando…
Lymphocyte recovery and clinical response in multiple myeloma patients receiving interferon alpha 2 beta after intensive therapy.
The recovery of immunoregulatory cells in the peripheral blood of patients with multiple myeloma receiving maintenance therapy with interferon alpha 2 beta (IFN-alpha 2 beta) after intensive therapy with high-dose melphalan and autologous bone marrow or peripheral blood stem cell rescue was studied....
Autores principales: | Millar, B. C., Bell, J. B., Powles, R. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074310/ https://www.ncbi.nlm.nih.gov/pubmed/8546912 |
Ejemplares similares
-
Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b.
por: Bell, J. B., et al.
Publicado: (1994) -
2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.
por: Millar, B. C., et al.
Publicado: (1995) -
Interferons Alpha, Beta, and Omega
por: Meager, Anthony
Publicado: (1998) -
Potent systemic therapy of Multiple Myeloma utilizing Oncolytic Vesicular stomatitis virus coding for Interferon-beta
por: Naik, Shruthi, et al.
Publicado: (2012) -
Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta
por: Abolfazli, Roya, et al.
Publicado: (2014)